Literature DB >> 16298338

Capacity of human beta-defensin expression in gene-transduced and cytokine-induced cells.

Chunyi Yin1, Hoa N Dang, Hai-Bo Zhang, Farzad Gazor, Daniel Kim, Ole E Sorensen, George T-J Huang.   

Abstract

The purpose of this study was to determine the capacity of cells transduced with human beta-defensins (HBDs) to express antimicrobial peptides, since sufficient expression level is required for effective antimicrobial activity. Retroviral vector pBabeNeo and lentiviral vector SIN18cPPTRhMLV (SIN18) carrying HBDs were utilized to transduce non-HBD-expressing cells such as fibroblasts or HBD-producing oral epithelial cells. We found that HBD-3 gene transfer to fibroblasts was possible not via retrovirus but by direct vector transfection. SIN18 had high transduction efficiencies (80.9-99.9%) and transduced cells expressed higher amounts of HBD-2 than those by pBabeNeo. Primary human gingival epithelial cells (HGECs) expressed greater amounts of HBD-2 than primary fibroblasts after lentiviral transduction. Additionally, HBD-2 secretion from transduced HGECs cells was further increased when stimulated with IL-1 or TNFalpha. Our data indicate that while HBD-2 expression is limited in primary fibroblasts, its expression in HGECs may be maximized by gene transduction plus cytokine induction.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16298338      PMCID: PMC3282591          DOI: 10.1016/j.bbrc.2005.11.020

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  64 in total

1.  Differential regulation of beta-defensin expression in human skin by microbial stimuli.

Authors:  Ole E Sørensen; Dharma R Thapa; Adam Rosenthal; Lide Liu; Alice A Roberts; Tomas Ganz
Journal:  J Immunol       Date:  2005-04-15       Impact factor: 5.422

2.  Beta defensin-3 engineered epidermis shows highly protective effect for bacterial infection.

Authors:  D Sawamura; M Goto; A Shibaki; M Akiyama; J R McMillan; Y Abiko; H Shimizu
Journal:  Gene Ther       Date:  2005-05       Impact factor: 5.250

3.  Transfer of a cathelicidin peptide antibiotic gene restores bacterial killing in a cystic fibrosis xenograft model.

Authors:  R Bals; D J Weiner; R L Meegalla; J M Wilson
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

4.  Human beta-defensin (hBD-1, -2) expression in dental pulp.

Authors:  H Dommisch; J Winter; Y Açil; A Dunsche; M Tiemann; S Jepsen
Journal:  Oral Microbiol Immunol       Date:  2005-06

5.  Transduction of well-differentiated airway epithelium by recombinant adeno-associated virus is limited by vector entry.

Authors:  R Bals; W Xiao; N Sang; D J Weiner; R L Meegalla; J M Wilson
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

6.  Production of beta-defensin antimicrobial peptides by the oral mucosa and salivary glands.

Authors:  M Mathews; H P Jia; J M Guthmiller; G Losh; S Graham; G K Johnson; B F Tack; P B McCray
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

Review 7.  Human beta-defensin-2.

Authors:  J M Schröder; J Harder
Journal:  Int J Biochem Cell Biol       Date:  1999-06       Impact factor: 5.085

8.  Correlation between beta-defensin expression and induction profiles in gingival keratinocytes.

Authors:  Sophie Joly; Connie C Organ; Georgia K Johnson; Paul B McCray; Janet M Guthmiller
Journal:  Mol Immunol       Date:  2004-12-15       Impact factor: 4.407

Review 9.  Psoriatic scales: a promising source for the isolation of human skin-derived antimicrobial proteins.

Authors:  Jürgen Harder; Jens-Michael Schröder
Journal:  J Leukoc Biol       Date:  2005-01-03       Impact factor: 4.962

10.  A cutaneous gene therapy approach to treat infection through keratinocyte-targeted overexpression of antimicrobial peptides.

Authors:  Marta Carretero; Marcela Del Río; Marta García; María José Escámez; Isabel Mirones; Luis Rivas; Cristina Balague; Jose Luis Jorcano; Fernando Larcher
Journal:  FASEB J       Date:  2004-09-29       Impact factor: 5.191

View more
  1 in total

1.  Mouse salivary glands and human beta-defensin-2 as a study model for antimicrobial gene therapy: technical considerations.

Authors:  Chunyi Yin; Hoa N Dang; Farzad Gazor; George T-J Huang
Journal:  Int J Antimicrob Agents       Date:  2006-09-11       Impact factor: 5.283

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.